721
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Advancing our quantitative understanding of radiotherapy normal tissue morbidity

&
Pages 577-579 | Received 18 Mar 2014, Accepted 18 Mar 2014, Published online: 13 Apr 2014

References

  • Tucker SL, Liao Z, Dinh J, Bian SX, Mohan R, Martel MK, et al. Is there an impact of heart exposure on the incidence of radiation pneumonitis?Analysis of data from a large clinical cohort. Acta Oncol 2014;53:590–6.
  • Beetz I, Steenbakkers RJ, Chouvalova O, Leemans CR, Doornaert P, van der Laan BF, et al. The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia. Acta Oncol 2014;53:597–604.
  • Appelt AL, Vogelius IR, Farr KP, Khalil AA, Bentzen SM. Towards individualized dose constraints: Adjusting the QUANTEC radiation pneumonitis model for clinical risk factors. Acta Oncol 2014;53:605–12.
  • Cella L, Liuzzi R, D’Avino V, Conson M, Di Biase A, Picardi M, et al. Pulmonary damage in Hodgkin’s lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury. Acta Oncol 2014;53: 613–9.
  • Johansen S, Fosså K, Nesvold IL, Malinen E, Fosså SD. Arm and shoulder morbidity following surgery and radiotherapy for breast cancer. Acta Oncol 2014;53:521–9.
  • Lindblom U, Garskog O, Kjellen E, Laurell G, Jaghagen EL, Wahlberg P, et al. Radiation-induced trismus in the ARTSCAN head and neck trial. Acta Oncol 2014;53:620–7.
  • Chow TL, Louie AV, Palma DA, D’Souza DP, Perera F, Rodrigues GB, et al. Radiation-induced lung injury after concurrent neoadjuvant chemoradiotherapy for locally advanced breast cancer. Acta Oncol 2014;53:697–701.
  • Huang EX, Hope AJ, Lindsay PE, Trovo M, El Naqa I, Deasy JO, et al. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol 2011;50:51–60.
  • Deasy J, Robinson C, Huang E, Molotievschi A, Bradley J. Independent test of a model to predict radiation pneumonitis after definitive radiation therapy for locally advanced non-small cell lung cancer: Heart irradiation is (again) a statistically significant risk factor (abstr). Int J Radiat Oncol Biol Phys 2012;84(Suppl 1):S32.
  • Novakova-Jiresova A, van Luijk P, van Goor H, Kampinga HH, Coppes RP. Pulmonary radiation injury: Identification of risk factors associated with regional hypersensitivity. Cancer Res 2005;65:3568–76.
  • van Luijk P, Novakova-Jiresova A, Faber H, Schippers JM, Kampinga HH, Meertens H, et al. Radiation damage to the heart enhances early radiation-induced lung function loss. Cancer Res 2005;65:6509–11.
  • van Luijk P, Faber H, Meertens H, Schippers JM, Langendijk JA, Brandenburg S, et al. The impact of heart irradiation on dose-volume effects in the rat lung. Int J Radiat Oncol Biol Phys 2007;69:552–9.
  • Ghobadi G, van der Veen S, Bartelds B, de Boer RA, Dickinson MG, de Jong JR, et al. Physiological interaction of heart and lung in thoracic irradiation. Int J Radiat Oncol Biol Phys 2012;84:e639–46.
  • Deasy JO, Moiseenko V, Marks L, Chao KS, Nam J, Eisbruch A. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 2010;76(Suppl 3): S58–63.
  • Deasy JO, Bentzen SM, Jackson A, Ten Haken RK, Yorke ED, Constine LS, et al. Improving normal tissue complication probability models: The need to adopt a “data-pooling” culture. Int J Radiat Oncol Biol Phys 2010;76(Suppl 3): S151–4.
  • Roelofs E, Persoon L, Nijsten S, Wiessler W, Dekker A, Lambin P. Benefits of a clinical data warehouse with data mining tools to collect data for a radiotherapy trial. Radiother Oncol 2013;108:174–9.
  • Roelofs E, Dekker A, Meldolesi E, van Stiphout RG, Valentini V, Lambin P. International data-sharing for radiotherapy research: An open-source based infrastructure for multicentric clinical data mining. Radiother Oncol 2014;110:370–4.
  • Mutter RW, Liu F, Abreu A, Yorke E, Jackson A, Rosenzweig KE. Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer. Int J Radiat Oncol Biol Phys 2012; 82:1783–90.
  • Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010;76(Suppl 3):S3–9.
  • Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76(Suppl 3):S10–9.
  • Jackson A, Marks LB, Bentzen SM, Eisbruch A, Yorke ED, Ten Haken RK, et al. The lessons of QUANTEC: Recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. Int J Radiat Oncol Biol Phys 2010;76(Suppl 3):S155–60.
  • Liu M, Moiseenko V, Agranovich A, Karvat A, Kwan W, Saleh ZH, et al. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A test of the QUANTEC-recommended NTCP model. Acta Oncol 2010;49:1040–4.
  • Trott KR, Doerr W, Facoetti A, Hopewell J, Langendijk J, van Luijk P, et al. Biological mechanisms of normal tissue damage: Importance for the design of NTCP models. Radiother Oncol 2012;105:79–85.
  • Mukesh M, Harris E, Jena R, Evans P, Coles C. Relationship between irradiated breast volume and late normal tissue complications: A systematic review. Radiother Oncol 2012;104:1–10.
  • Vogelius IR, Bentzen SM. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol 2012;51:975–83.
  • Lee TF, Fang FM. Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy. Radiother Oncol 2013;106: 352–8.
  • Ravn S, Holmberg M, Sørensen P, Frøkjær JB, Carl J. Differences in supratentorial white matter diffusion after radiotherapy – new biomarker of normal brain tissue damage?Acta Oncol 2013;52:1314–9.
  • De Ruysscher D, Sharifi H, Defraene G, Kerns SL, Christiaens M, De Ruyck K, et al. Quantification of radiation-induced lung damage with CT scans: The possible benefit for radiogenomics. Acta Oncol 2013;52:1405–10.
  • Thor M, Apte A, Deasy JO, Karlsdóttir À, Moiseenko V, Liu M, et al. Dose/volume-response relations for rectal morbidity using planned and simulated motion-inclusive dose distributions. Radiother Oncol 2013;109:388–93.
  • Stenmark MH, Conlon AS, Johnson S, Daignault S, Litzenberg D, Marsh R, et al. Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer.Radiother Oncol 2014;110:291–7.
  • Peeters ST, Lebesque JV, Heemsbergen WD, van Putten WL, Slot A, Dielwart MF, et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2006;64:1151–61.
  • Heemsbergen WD, Al-Mamgani A, Witte MG, van Herk M, Pos FJ, Lebesque JV. Urinary obstruction in prostate cancer patients from the Dutch trial (68 Gy vs. 78 Gy): Relationships with local dose, acute effects, and baseline characteristics. Int J Radiat Oncol Biol Phys 2010;78:19–25.
  • Liang Y, Messer K, Rose BS, Lewis JH, Jiang SB, Yashar CM, et al. Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: Principal component analysis on high dimensional data. Int J Radiat Oncol Biol Phys 2010;78:912–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.